Smoking has a dose dependent impact on disease activity in axial spondyloarthritis and accelerates the progression of patients onto biologic medicines, New Zealand research has found. The novel finding comes from the Spondyloarthritis Genetics and the Environment study – a multicentre, longitudinal study that has followed 368 participants for about five years. Rheumatologist Associate Professor ...
Smoking accelerates disease progression in axSpA
21 May 2017